Market Highlights
The Global Blockchain In Pharmaceutical Supply Chain
Management Market Research report is expected to register an
approximate CAGR of 23% during the forecast period.
The portfolio of pharmaceutical companies has become more
diversified in recent years with the arrival of nanotechnology, tissue
regeneration, and stem cell research. These new products need a process of
manufacture and distribution need to be safer than conventional chemical
molecules by their intrinsic characteristics. In addition, the substantial
growth of emerging markets, the environmental pressures for sustainable
progress and the growing scrutiny by regulatory authorities (new regulations,
broader risk management, etc.) back the idea that a new approach to
manufacturing and distribution would be needed in future years to meet the
needs of the coming future.
Segmentation
The global blockchain in pharmaceutical supply chain
management market report is segmented on the basis of
application, end user, and region.
On the basis of application, the global blockchain in
pharmaceutical supply chain management market is segmented into product traceability, risk and compliance management,
payment & settlement, others. The market by end user is segmented
into manufacturers, distributors, healthcare providers
On the bases of region, the global blockchain in pharmaceutical
supply chain management market is segmented into the Americas, Europe,
Asia-Pacific, and the Middle East & Africa. The Americas is expected to
hold the largest market share and the Middle East & Africa with a low
market share during the forecasted period.
Key Players
Some of the key players in the global blockchain in
pharmaceutical supply chain management market are IBM, Microsoft, SAP SE,
Oracle, Tibco Software, Auxesis Group, Omnichain, Vechain Foundation,
Chainvine, Applied Blockchain, AWS, Huawei, Guardtime, BTL Group, Bitfury,
Digital Treasury Corporation, Blockverify, Nodalblock, Peer Ledger and others.
Regional Analysis
The healthcare sector and its supporting IT infrastructure are
going through dramatic changes, all of which impact the claims management
process and lead to improving the technology. Many healthcare organizations use
robotic process automation, intelligent EDI integration, insurance discovery,
and patient solutions all within their workflow platform to dramatically
enhance the overall process. The adoption of various software has increased
profit.
Infrastructure and technology are continuously evolving in
developing regions such as Asia-Pacific. A number of different multinational
and local companies are involved in developing their markets in this region
owing to the developing economy and increasing government support. An
increasing number of healthcare companies have provided a good opportunity for
the development of the blockchain in pharmaceutical supply chain management
market.
Furthermore, in the United States, the Drugs Quality and Safety
Act (DQSA) was promoted by Congress on November 27, 2013. This outlines the
steps to be taken to develop an interoperable electronic supply chain
management system. This will strengthen the FDA's capability to protect
consumers from exposure to drugs that could be fake or from the black market.
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and intelligence
services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1 628
258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment